Two Sigma Advisers’s Arcutis Biotherapeutics ARQT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-156,100	Closed	-$4.53M	–	168
2025 Q4	$4.53M	Buy	156,100 +141,000	+934%	+$3.61M	0.01%	854
2025 Q3	$285K	Sell	15,100 -600	-4%	-$9.46K	﹤0.01%	2009
2025 Q2	$220K	Sell	15,700 -55,100	-78%	-$772K	﹤0.01%	2087
2025 Q1	$1.11M	Buy	+70,800	New	+$997K	﹤0.01%	1429
2024 Q4	–	Sell	-182,800	Closed	-$1.7M	–	2337
2024 Q3	$1.7M	Sell	182,800 -305,800	-63%	-$3.02M	﹤0.01%	1156
2024 Q2	$4.54M	Buy	488,600 +157,700	+48%	+$1.43M	0.01%	801
2024 Q1	$3.28M	Buy	+330,900	New	+$2.47M	0.01%	961
2023 Q2	–	Sell	-16,000	Closed	-$176K	–	2381
2023 Q1	$176K	Sell	16,000 -119,600	-88%	-$1.73M	﹤0.01%	2287
2022 Q4	$2.01M	Buy	135,600 +64,400	+90%	+$1.13M	0.01%	1249
2022 Q3	$1.36M	Buy	+71,200	New	+$1.61M	﹤0.01%	1373
2021 Q4	–	Sell	-27,700	Closed	-$662K	–	2614
2021 Q3	$662K	Sell	27,700 -34,200	-55%	-$780K	﹤0.01%	1806
2021 Q2	$1.69M	Sell	61,900 -15,700	-20%	-$442K	﹤0.01%	1376
2021 Q1	$2.25M	Buy	77,600 +48,300	+165%	+$1.51M	0.01%	1207
2020 Q4	$824K	Buy	+29,300	New	+$718K	﹤0.01%	1659